小肾脏病变的多参数定量MR分析:与手术病理的相关性
本回顾性研究纳入98个≤3 cm的肾脏病变,评估ADC、化学位移信号强度指数及强化程度在鉴别良恶性及亚型中的价值。结果示良恶性间ADC与SII无差异,皮髓质期绝对强化良性高于恶性;ADC比值可区分乳头状RCC与良性病变,SII可区分透明细胞RCC与其他RCC。
要点
- 皮髓质期绝对强化良性病变高于恶性病变,但排除乳头状RCC后差异消失。
- ADC与SII不能可靠鉴别肾脏病变的良恶性。
- ADC比值有助于区分乳头状RCC与良性病变,SII有助于区分透明细胞RCC与其他RCC。
核心结论
- 皮髓质期强化是鉴别特征,但扩散和化学位移成像的定量指标不能可靠鉴别良恶性病变;定量评估可能有助于区分某些良恶性病变亚型。
研究设计与样本
- 回顾性研究,纳入98个≤3 cm的肾脏病变,均有MRI及手术病理对照;记录扫描仪场强、病变位置和大小;两名对手术病理不知情的阅片者独立测量ADC比值、SII及皮髓质期和肾实质期的绝对/相对强化。
诊断标准与关键数值
- 良性病变皮髓质期绝对强化高于恶性病变(150.0 ± 111.5 vs. 81.1 ± 74.8,p = 0.0115),排除pRCC后该差异未持续;pRCC的ADC比值低于良性病变(0.74 ± 0.35 vs. 1.03 ± 0.46,p = 0.0246);ccRCC的SII高于其他RCC(0.09 ± 0.22 vs. 0.001 ± 0.26,p = 0.0412);嗜酸细胞瘤和AML的皮髓质期绝对强化分别高于ccRCC和pRCC(145.6 ± 65.2 vs. 107.2 ± 85.3,p = 0.043;186.2 ± 93.9 vs. 37.6 ± 35.3,p = 0.0108)。
临床应用与阅片要点
- 阅片时可关注皮髓质期绝对强化以辅助鉴别良恶性,但需注意排除pRCC后差异消失;ADC比值和SII可能有助于区分部分亚型,但ADC与SII不能可靠鉴别良恶性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: The purpose of the study is to evaluate the utility of apparent diffusion coefficient (ADC), chemical shift signal intensity index (SII), and contrast enhancement in distinguishing between benign lesions and renal cell carcinoma (RCC) and between subtypes of renal lesions.
METHODS: This retrospective study included 98 renal lesions (≤ 3 cm) on MRI with correlative surgical pathology. Scanner field strength, lesion location, and size were recorded. Two readers blinded to surgical pathology independently measured ADC ratio (ADC lesion/ADC non-lesion kidney), SII, and absolute/relative enhancement in the corticomedullary and nephrographic phases of contrast.
RESULTS: There were 76 malignant and 22 benign lesions. 42 RCC were clear cell (ccRCC), 19 papillary (pRCC), 5 chromophobe (cbRCC). Benign lesions included both solid and cystic lesions. Interreader agreement for all variables was good-excellent (ICC 0.70-0.91). There was no difference in ADC or SII between benign and malignant lesions. There was greater absolute corticomedullary enhancement of benign versus malignant lesions (150.0 ± 111.5 vs. 81.1 ± 74.8, p = 0.0115), which did not persist when excluding pRCC. For lesion subtype differentiation, ADCratio for pRCC was lower than benign lesions (0.74 ± 0.35 vs. 1.03 ± 0.46, p = 0.0246). ccRCC demonstrated greater SII than other RCC (0.09 ± 0.22 vs. 0.001 ± 0.26, p = 0.0412). Oncocytomas and angiomyolipoma (AML) showed greater absolute corticomedullary enhancement than ccRCC and pRCC (145.6 ± 65.2 vs. 107.2 ± 85.3, p = 0.043 and 186.2 ± 93.9 vs. 37.6 ± 35.3, p = 0.0108), respectively.
CONCLUSIONS: While corticomedullary-phase enhancement was a differentiating feature, quantitative metrics from diffusion and chemical shift imaging cannot reliably differentiate benign from malignant lesions. Quantitative assessment may be useful in differentiating some benign and malignant lesion subtypes.
引用
- Yano M, Fowler KJ, Srisuwan S, et al. Quantitative multiparametric MR analysis of small renal lesions: correlation with surgical pathology. Abdom Radiol (NY). 2018. PMID: 29691619. doi:10.1007/s00261-018-1612-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。